CAR T Cell: Do Benefits Still Outweigh Risks?

Despite concerns about the development of secondary T-cell malignancies due to CAR T-cell immunotherapy, experts still believed that the benefits outweigh the risks.

Related Keywords

United States ,Philadelphia ,Pennsylvania ,Maryland ,Silver Spring ,University Of Pennsylvania ,Rahul Banerjee ,Peter Marks ,Marco Ruella ,Lymphoma Program ,Drug Administration ,Research In Silver Spring ,Division Of Hematology ,University Of Washington ,New England Journal ,Biologics Evaluation ,Nature Medicine ,Hodgkinb Cell ,Cautious Reassurance Urged ,Discussion With ,Blood Advances ,Touch With ,Biologic Therapy ,Iologics ,Chimeric Antigen Receptort Cell Therapy ,Chimeric Antigen Receptors ,Himeric Immunoreceptors ,Himerict Cell Receptors ,Rtificialt Cell Receptors ,Art Chimaeric Antigen Receptort Cell Therapy Receptors Immunoreceptors Chimaerict ,Skin Cancer ,Alignant Skin Neoplasm ,Non Hodgkin Amp 039s Lymphoma ,Non Hodgkin Lymphoma ,